Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency

被引:315
作者
Singh, Amit Kumar [1 ]
Cabral, Celia [2 ,3 ]
Kumar, Ramesh [1 ]
Ganguly, Risha [1 ]
Rana, Harvesh Kumar [1 ]
Gupta, Ashutosh [1 ]
Lauro, Maria Rosaria [4 ]
Carbone, Claudia [5 ]
Reis, Flavio [2 ,3 ,6 ]
Pandey, Abhay K. [1 ]
机构
[1] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India
[2] Univ Coimbra, Coimbra Inst Clin & Biomed Res iCBR, Fac Med, P-3000548 Coimbra, Portugal
[3] Univ Coimbra, CIBB Consortium, P-3000548 Coimbra, Portugal
[4] Univ Salerno, Dept Pharm, Lab Pharmaceut Technol, I-84084 Fisciano, SA, Italy
[5] Univ Catania, Dept Drug Sci, Lab Drug Delivery Technol, I-95125 Catania, Italy
[6] Univ Coimbra, Fac Med, Inst Pharmacol & Expt Therapeut, P-3000548 Coimbra, Portugal
关键词
dietary polyphenols; gut microbiota; dysbiosis; gastrointestinal diseases; metabolic disorders; delivery systems; SOLID LIPID NANOPARTICLES; INTESTINAL MICROBIOTA; IN-VITRO; HEALTH; IMPACT; RESVERATROL; METABOLISM; EXPRESSION; COLITIS; ANTHOCYANINS;
D O I
10.3390/nu11092216
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The human intestine contains an intricate ecological community of dwelling bacteria, referred as gut microbiota (GM), which plays a pivotal role in host homeostasis. Multiple factors could interfere with this delicate balance, including genetics, age, antibiotics, as well as environmental factors, particularly diet, thus causing a disruption of microbiota equilibrium (dysbiosis). Growing evidences support the involvement of GM dysbiosis in gastrointestinal (GI) and extra-intestinal cardiometabolic diseases, namely obesity and diabetes. This review firstly overviews the role of GM in health and disease, then critically reviews the evidences regarding the influence of dietary polyphenols in GM based on preclinical and clinical data, ending with strategies under development to improve efficiency of delivery. Although the precise mechanisms deserve further clarification, preclinical and clinical data suggest that dietary polyphenols present prebiotic properties and exert antimicrobial activities against pathogenic GM, having benefits in distinct disorders. Specifically, dietary polyphenols have been shown ability to modulate GM composition and function, interfering with bacterial quorum sensing, membrane permeability, as well as sensitizing bacteria to xenobiotics. In addition, can impact on gut metabolism and immunity and exert anti-inflammatory properties. In order to overcome the low bioavailability, several different approaches have been developed, aiming to improve solubility and transport of dietary polyphenols throughout the GI tract and deliver in the targeted intestinal regions. Although more research is still needed, particularly translational and clinical studies, the biotechnological progresses achieved during the last years open up good perspectives to, in a near future, be able to improve the use of dietary polyphenols modulating GM in a broad range of disorders characterized by a dysbiotic phenotype.
引用
收藏
页数:21
相关论文
共 116 条
[1]   Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats [J].
Abel Lozano-Perez, Antonio ;
Rodriguez-Nogales, Alba ;
Ortiz-Cullera, Victor ;
Algieri, Francesca ;
Garrido-Mesa, Jose ;
Zorrilla, Pedro ;
Elena Rodriguez-Cabezas, M. ;
Garrido-Mesa, Natividad ;
Utrilla, M. Pilar ;
De Matteis, Laura ;
Martinez de la Fuente, Jesus ;
Luis Cenis, Jose ;
Galvez, Julio .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :4507-4520
[2]   Age-dependent changes in GI physiology and microbiota: time to reconsider? [J].
An, Ran ;
Wilms, Ellen ;
Masclee, Ad A. M. ;
Smidt, Hauke ;
Zoetendal, Erwin G. ;
Jonkers, Daisy .
GUT, 2018, 67 (12) :2213-2222
[3]   Epidemiology and risk factors for IBD [J].
Ananthakrishnan, Ashwin N. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (04) :205-217
[4]   Procyanidin Dimers A1, A2, and B2 Are Absorbed without Conjugation or Methylation from the Small Intestine of Rats [J].
Appeldoorn, Maaike M. ;
Vincken, Jean-Paul ;
Gruppen, Harry ;
Hollman, Peter C. H. .
JOURNAL OF NUTRITION, 2009, 139 (08) :1469-1473
[5]   Role of the Microbiota in Immunity and Inflammation [J].
Belkaid, Yasmine ;
Hand, Timothy W. .
CELL, 2014, 157 (01) :121-141
[6]   Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis [J].
Bellavia, Maurizio ;
Tomasello, Giovanni ;
Romeo, Marcello ;
Damiani, Provvidenza ;
Lo Monte, Attilio I. ;
Lozio, Luciano ;
Campanella, Claudia ;
Gammazza, Antonella Marino ;
Rappa, Francesca ;
Zummo, Giovanni ;
Cocchi, Massimo ;
de Macario, Everly Conway ;
Macario, Alberto J. L. ;
Cappello, Francesco .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2013, 202 (06) :393-406
[7]   Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation [J].
Bennett, Brian J. ;
Vallim, Thomas Q. de Aguiar ;
Wang, Zeneng ;
Shih, Diana M. ;
Meng, Yonghong ;
Gregory, Jill ;
Allayee, Hooman ;
Lee, Richard ;
Graham, Mark ;
Crooke, Rosanne ;
Edwards, Peter A. ;
Hazen, Stanley L. ;
Lusis, Aldons J. .
CELL METABOLISM, 2013, 17 (01) :49-60
[8]   Gut Microbiome Response to Sucralose and Its Potential Role in Inducing Liver Inflammation in Mice [J].
Bian, Xiaoming ;
Chi, Liang ;
Gao, Bei ;
Tu, Pengcheng ;
Ru, Hongyu ;
Lu, Kun .
FRONTIERS IN PHYSIOLOGY, 2017, 8
[9]   Impact of gut microbiota on diabetes mellitus [J].
Blandino, G. ;
Inturri, R. ;
Lazzara, F. ;
Di Rosa, M. ;
Malaguarnera, L. .
DIABETES & METABOLISM, 2016, 42 (05) :303-315
[10]   Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats [J].
Bowey, E ;
Adlercreutz, H ;
Rowland, I .
FOOD AND CHEMICAL TOXICOLOGY, 2003, 41 (05) :631-636